Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
腫瘍関連糖鎖抗原を標的として癌を治療及び予防するための組成物及び方法
Document Type and Number:
Japanese Patent JP6692294
Kind Code:
B2
Abstract:
Compositions useful to induce anti-TACA immune response and kits comprising the same and methods of using the compositions to treat and prevent cancer are disclosed. Isolated human antibodies which bind to a carbohydrate mimetic peptide and methods of making the same and using the same to treat and prevent cancer are disclosed. Isolated human NK cells useful to kill tumor cells, and isolated human dendritic cells, and methods of making the same and using the same to treat and prevent cancer are disclosed.

Inventors:
Thomas Keever-Emmons
Anastus Persov
Beja Torra Carvassi
Application Number:
JP2016531920A
Publication Date:
May 13, 2020
Filing Date:
July 31, 2014
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
BioVentures, LLC
International Classes:
A61K39/00; A61K31/138; A61K31/337; A61K31/475; A61K31/675; A61K31/69; A61K31/704; A61K33/243; A61K35/17; A61K39/39; A61K39/395; A61K45/00; A61P35/00
Other References:
Technical Reports (TRs),Defense Technical Information Center(アメリカ国防技術情報センター),2009年 5月,[online],[平成30年3月19日検索],Accession No.ADA508503,URL,http://www.dtic.mil/docs/citations/ADA508503
Journal of Clinical Oncology,2011年,Vol.29,No.21,p2924-2932
Journal of Immunotherapy,2010年,Vol.33,No.6,p630-638
Journal of Translational Medicine,2012年,Vol.10,Article No.156,p1-12
Cancer Research,2008年,Vol.68,No.9 Suppl.,Abstract No.4648,URL,http://cancerres.aacrjournals.org/content/68/9_Supplement/4648
Study NCT01390064,2013年 2月19日,[online],[平成31年3月12日検索],Retrieved from the internet:,URL,https://clinicaltrials.gov/ct2/history/NCT01390064?V_6=View#StudyPageTop
Attorney, Agent or Firm:
Junji Yuda
Noriyuki Takebayashi